Rotten Tomato Stocks
No Result
View All Result
  • News
    Samsung’s Profit Plummets Amid Global Economic Woes

    Samsung’s Profit Plummets Amid Global Economic Woes

    Stocks Sink as Markets Brace for Big Week With Fed, Earnings

    Stocks Sink as Markets Brace for Big Week With Fed, Earnings

    Low-Cost Fashion Chain H&M Reports 4th-Quarter Loss

    Low-Cost Fashion Chain H&M Reports 4th-Quarter Loss

    Dow profit and sales fall short of estimates, aims to cut $1 billion in costs in 2023

    Dow profit and sales fall short of estimates, aims to cut $1 billion in costs in 2023

  • NYSE
    Caterpillar stock falls after profit misses expectations, while revenue beats

    Caterpillar stock falls after profit misses expectations, while revenue beats

    Ameren Corp. stock falls Tuesday, underperforms market

    Ameren Corp. stock falls Tuesday, underperforms market

    Ford Motor (NYSE:F) Short Interest Down 5.6% in January

    Ford Motor (NYSE:F) Short Interest Down 5.6% in January

    Johnson & Johnson, Chevron share losses lead Dow’s 261-point drop

    Johnson & Johnson, Chevron share losses lead Dow’s 261-point drop

  • NASDAQ
    Super Micro stock falls after weaker sales guidance for fiscal Q3

    Super Micro stock falls after weaker sales guidance for fiscal Q3

    Western Digital Corp. stock falls Tuesday, underperforms market

    Western Digital Corp. stock falls Tuesday, underperforms market

    Datadog, Inc. (NASDAQ:DDOG) Sees Large Drop in Short Interest

    Datadog, Inc. (NASDAQ:DDOG) Sees Large Drop in Short Interest

    Orchestra BioMed Down Almost 17% on Second Day of Nasdaq Trading

    Orchestra BioMed Down Almost 17% on Second Day of Nasdaq Trading

  • OTC
    China Eastern Airlines 3Q Loss Widens on Low Travel Demand

    China Eastern Airlines 3Q Loss Widens on Low Travel Demand

    Corus Entertainment 4Q Profit Falls

    Corus Entertainment 4Q Profit Falls

    Nintendo Co. Ltd. ADR falls Monday, still outperforms market

    Nintendo Co. Ltd. ADR falls Monday, still outperforms market

    Ocado Group PLC Revenue of Ocado Retail in Q3 Fell 10.6%

    Ocado Group PLC Revenue of Ocado Retail in Q3 Fell 10.6%

  • TSX
    US Seeks to Fine Air Canada $25.5 Million Over Slow Refunds

    US Seeks to Fine Air Canada $25.5 Million Over Slow Refunds

    S&P/TSX composite falls on drop in materials sector, loonie tops 81 cents US

    S&P/TSX composite falls on drop in materials sector, loonie tops 81 cents US

    Bitcoin Is Falling: Should You Buy the Dip?

    Bitcoin Is Falling: Should You Buy the Dip?

    CN Rail Stock Is So Undervalued That it’s Absurd

    CN Rail Stock Is So Undervalued That it’s Absurd

  • News
    Samsung’s Profit Plummets Amid Global Economic Woes

    Samsung’s Profit Plummets Amid Global Economic Woes

    Stocks Sink as Markets Brace for Big Week With Fed, Earnings

    Stocks Sink as Markets Brace for Big Week With Fed, Earnings

    Low-Cost Fashion Chain H&M Reports 4th-Quarter Loss

    Low-Cost Fashion Chain H&M Reports 4th-Quarter Loss

    Dow profit and sales fall short of estimates, aims to cut $1 billion in costs in 2023

    Dow profit and sales fall short of estimates, aims to cut $1 billion in costs in 2023

  • NYSE
    Caterpillar stock falls after profit misses expectations, while revenue beats

    Caterpillar stock falls after profit misses expectations, while revenue beats

    Ameren Corp. stock falls Tuesday, underperforms market

    Ameren Corp. stock falls Tuesday, underperforms market

    Ford Motor (NYSE:F) Short Interest Down 5.6% in January

    Ford Motor (NYSE:F) Short Interest Down 5.6% in January

    Johnson & Johnson, Chevron share losses lead Dow’s 261-point drop

    Johnson & Johnson, Chevron share losses lead Dow’s 261-point drop

  • NASDAQ
    Super Micro stock falls after weaker sales guidance for fiscal Q3

    Super Micro stock falls after weaker sales guidance for fiscal Q3

    Western Digital Corp. stock falls Tuesday, underperforms market

    Western Digital Corp. stock falls Tuesday, underperforms market

    Datadog, Inc. (NASDAQ:DDOG) Sees Large Drop in Short Interest

    Datadog, Inc. (NASDAQ:DDOG) Sees Large Drop in Short Interest

    Orchestra BioMed Down Almost 17% on Second Day of Nasdaq Trading

    Orchestra BioMed Down Almost 17% on Second Day of Nasdaq Trading

  • OTC
    China Eastern Airlines 3Q Loss Widens on Low Travel Demand

    China Eastern Airlines 3Q Loss Widens on Low Travel Demand

    Corus Entertainment 4Q Profit Falls

    Corus Entertainment 4Q Profit Falls

    Nintendo Co. Ltd. ADR falls Monday, still outperforms market

    Nintendo Co. Ltd. ADR falls Monday, still outperforms market

    Ocado Group PLC Revenue of Ocado Retail in Q3 Fell 10.6%

    Ocado Group PLC Revenue of Ocado Retail in Q3 Fell 10.6%

  • TSX
    US Seeks to Fine Air Canada $25.5 Million Over Slow Refunds

    US Seeks to Fine Air Canada $25.5 Million Over Slow Refunds

    S&P/TSX composite falls on drop in materials sector, loonie tops 81 cents US

    S&P/TSX composite falls on drop in materials sector, loonie tops 81 cents US

    Bitcoin Is Falling: Should You Buy the Dip?

    Bitcoin Is Falling: Should You Buy the Dip?

    CN Rail Stock Is So Undervalued That it’s Absurd

    CN Rail Stock Is So Undervalued That it’s Absurd

No Result
View All Result
Rotten Tomato Stocks
No Result
View All Result

Supernus Pharmaceuticals (NASDAQ:SUPN) Seems To Use Debt Rather Sparingly

Editorial Staff by Editorial Staff
July 5, 2021
0
Supernus Pharmaceuticals (NASDAQ:SUPN) Seems To Use Debt Rather Sparingly

David Iben put it well when he said, ‘Volatility is not a risk we care about. What we care about is avoiding the permanent loss of capital.’ When we think about how risky a company is, we always like to look at its use of debt, since debt overload can lead to ruin. Importantly, Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) does carry debt. But should shareholders be worried about its use of debt?

Why Does Debt Bring Risk?

Debt is a tool to help businesses grow, but if a business is incapable of paying off its lenders, then it exists at their mercy. Ultimately, if the company can’t fulfill its legal obligations to repay debt, shareholders could walk away with nothing. However, a more usual (but still expensive) situation is where a company must dilute shareholders at a cheap share price simply to get debt under control. Of course, debt can be an important tool in businesses, particularly capital heavy businesses. The first thing to do when considering how much debt a business uses is to look at its cash and debt together.

What Is Supernus Pharmaceuticals’s Net Debt?

The image below, which you can click on for greater detail, shows that at March 2021 Supernus Pharmaceuticals had debt of US$366.0m, up from US$349.2m in one year. But on the other hand it also has US$391.1m in cash, leading to a US$25.1m net cash position.

debt-equity-history-analysis
NasdaqGM:SUPN Debt to Equity History July 5th 2021

A Look At Supernus Pharmaceuticals’ Liabilities

Zooming in on the latest balance sheet data, we can see that Supernus Pharmaceuticals had liabilities of US$240.8m due within 12 months and liabilities of US$512.2m due beyond that. Offsetting these obligations, it had cash of US$391.1m as well as receivables valued at US$127.1m due within 12 months. So its liabilities total US$234.8m more than the combination of its cash and short-term receivables.

Since publicly traded Supernus Pharmaceuticals shares are worth a total of US$1.61b, it seems unlikely that this level of liabilities would be a major threat. Having said that, it’s clear that we should continue to monitor its balance sheet, lest it change for the worse. Despite its noteworthy liabilities, Supernus Pharmaceuticals boasts net cash, so it’s fair to say it does not have a heavy debt load!

And we also note warmly that Supernus Pharmaceuticals grew its EBIT by 13% last year, making its debt load easier to handle. When analysing debt levels, the balance sheet is the obvious place to start. But it is future earnings, more than anything, that will determine Supernus Pharmaceuticals’s ability to maintain a healthy balance sheet going forward.

Finally, a company can only pay off debt with cold hard cash, not accounting profits. Supernus Pharmaceuticals may have net cash on the balance sheet, but it is still interesting to look at how well the business converts its earnings before interest and tax (EBIT) to free cash flow, because that will influence both its need for, and its capacity to manage debt. During the last three years, Supernus Pharmaceuticals generated free cash flow amounting to a very robust 86% of its EBIT, more than we’d expect. That puts it in a very strong position to pay down debt.

Summing up

Although Supernus Pharmaceuticals’s balance sheet isn’t particularly strong, due to the total liabilities, it is clearly positive to see that it has net cash of US$25.1m. The cherry on top was that in converted 86% of that EBIT to free cash flow, bringing in US$163m. So we don’t think Supernus Pharmaceuticals’s use of debt is risky. The balance sheet is clearly the area to focus on when you are analysing debt. However, not all investment risk resides within the balance sheet – far from it.

Related Posts

Super Micro stock falls after weaker sales guidance for fiscal Q3
NASDAQ

Super Micro stock falls after weaker sales guidance for fiscal Q3

February 1, 2023
Western Digital Corp. stock falls Tuesday, underperforms market
NASDAQ

Western Digital Corp. stock falls Tuesday, underperforms market

February 1, 2023
Datadog, Inc. (NASDAQ:DDOG) Sees Large Drop in Short Interest
NASDAQ

Datadog, Inc. (NASDAQ:DDOG) Sees Large Drop in Short Interest

February 1, 2023
Orchestra BioMed Down Almost 17% on Second Day of Nasdaq Trading
NASDAQ

Orchestra BioMed Down Almost 17% on Second Day of Nasdaq Trading

January 31, 2023
Load More
Next Post
Is Shenandoah Telecommunications (NASDAQ:SHEN) A Risky Investment?

Is Shenandoah Telecommunications (NASDAQ:SHEN) A Risky Investment?

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

I agree to the Terms & Conditions and Privacy Policy.

POPULAR NEWS

CNH Industrial (NYSE:CNHI) Use Of Debt Could Be Considered Risky

CNH Industrial (NYSE:CNHI) Use Of Debt Could Be Considered Risky

April 14, 2021
CN Rail Stock Is So Undervalued That it’s Absurd

CN Rail Stock Is So Undervalued That it’s Absurd

May 2, 2021
US Seeks to Fine Air Canada $25.5 Million Over Slow Refunds

US Seeks to Fine Air Canada $25.5 Million Over Slow Refunds

June 17, 2021
Ocado Group PLC Revenue of Ocado Retail in Q3 Fell 10.6%

Ocado Group PLC Revenue of Ocado Retail in Q3 Fell 10.6%

September 14, 2021
10 Warning Signs That Should Tell You “This Stock is in Trouble”

10 Warning Signs That Should Tell You “This Stock is in Trouble”

November 11, 2019

EDITOR'S PICK

Avast Threat Labs finds U.S. most vulnerable to tech support fraud

Avast Threat Labs finds U.S. most vulnerable to tech support fraud

June 29, 2021
Credit Suisse Fined for Facilitating Cocaine Cash Laundering

Credit Suisse Fined for Facilitating Cocaine Cash Laundering

June 27, 2022
Why Anaplan Stock Dropped 12% This Morning

Why Anaplan Stock Dropped 12% This Morning

May 27, 2021
Dow falls 550 points, S&P 500 breaks below 4,000 as stocks head for worst day in nearly a month

Dow falls 550 points, S&P 500 breaks below 4,000 as stocks head for worst day in nearly a month

December 6, 2022

Stay Updated

Get breaking news delivered straight into your inbox

Nothing in this publication should be considered as personalized financial advice. We are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Please consult a licensed financial advisor before making any investment decision. This is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. Rotten Tomato stocks is a wholly-owned subsidiary of Grainne Capital Limited.
While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.

Rotten Tomato Stocks cover the companies and markets that are declining, failing or headed for disaster. We help investors spot the down tends and recognize when something smells rotten.

RECENT POSTS

Samsung’s Profit Plummets Amid Global Economic Woes

Caterpillar stock falls after profit misses expectations, while revenue beats

Ameren Corp. stock falls Tuesday, underperforms market

POPULAR POSTS

Ford Motor (NYSE:F) Short Interest Down 5.6% in January

Super Micro stock falls after weaker sales guidance for fiscal Q3

Western Digital Corp. stock falls Tuesday, underperforms market

© Copyright 2021 RottenTomatoStocks. All Rights Reserved 

Disclaimer | Privacy Policy

No Result
View All Result
  • HOME
  • NEWS
  • NYSE
  • NASDAQ
  • OTC
  • TSX

© 2021 RottenTomatoStocks.com

error: Content is protected !!
This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.